Condition category
Pregnancy and Childbirth
Date applied
13/12/2013
Date assigned
12/02/2014
Last edited
24/10/2016
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
In Burkina Faso, population-based caesarean section rates are still very low (between 2% and 3.5% according to rural and urban settings). However, institutional caesarean section rates are growing quickly since the implementation of the caesarean section fee exemption policy in 2006. Excessive increase in caesarean section rates can have negative impacts on maternal and perinatal health. Many initiatives have been tested but not assessed rigorously. The aim of this study is to assess whether a clinical audit and training approach can improve medical practices and reduce non-medically justified caesarean sections in referral hospitals in Burkina Faso.

Who can participate?
Referral hospitals in Burkina Faso equipped with a functional operating room and women giving birth by caesarean section in those participating hospitals.

What does the study involve?
Hospitals will be randomly allocated to one of two groups: an intervention group or a control group.
For hospitals in the intervention group, a combination of two approaches will be used to improve the way health personnel decide that women are eligible for caesarean delivery: they will be trained to use a system (called algorithms-based clinical audit) in order to decide that a caesarean section is needed and they will also be trained on how to use mobile phone technology (SMS) for feedback. This will last one year. There will some data collection 6 months before. For hospitals in the control group, there will be no changes to normal practices.

What are the possible benefits and risks of participating?
According to previous studies, the approach under review could change future behaviors.
There are no risks involved.

Where is the study run from?
We will include 22 centers: 9 regional hospitals and 13 district hospitals; all the centers are in Burkina Faso.

When is the study starting and how long is it expected to run for?
March 2014 to May 2016

Who is funding the study?
This study is promoted by the French Research Institute for Development (IRD). The study is funded by the Fonds Francais Muskoka Canal multi-latéral, UNICEF – WHO/OMS - UNFPA – ONU Femmes/UN Women, the Canadian Institute for Health Research (CIHR) and the French Embassy in Burkina Faso.

Who is the main contact?
There are six main contacts:
Charles Kabore, principal investigator, kaborewendyam@yahoo.fr
Séni Kouanda, co-researcher, skouanda@irss.bf
Valéry Ridde, co-researcher, valery.ridde@umontreal.ca
Ludovic Queuille, co-researcher, queuille@help-ev.de
Alexandre Dumont, co-researcher, alexandre.dumont@ird.fr
Cécile Bodin, project administrator, cecile.bodin@ird.fr

Trial website

Contact information

Type

Scientific

Primary contact

Mr Charles Kabore

ORCID ID

Contact details

Institut de Recherche pour le Développement (IRD)
UMR 216
Avenue de l'Observatoire
Paris
75006
France
-
kaborewendyam@yahoo.fr

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Effectiveness of clinical audit combined with training in reducing the rate of abusive (not medically justified) caesarean sections in hospitals in Burkina Faso: a cluster randomized controlled trial

Acronym

DECIDE

Study hypothesis

Clinical audits combined with training and recalls reduce unjustified caesarean delivery by 50% compared to the control group (no external intervention).

Ethics approval

National Ethics Committee of Burkina Faso, 05/02/2014

Study design

Cluster randomized controlled trial

Primary study design

Interventional

Secondary study design

Cluster randomised trial

Trial setting

Hospitals

Trial type

Other

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Caesarean section

Intervention

Multi-factorial intervention combining education, clinical audit with feedback and reminders concerning the indications for caesarean section.

Methodology for each treatment arm:
1. Intervention group activities: Professionals from the intervention group will be first trained in evidence-based practice using algorithms for the decision of caesarean section and vignettes (one day). The initial training will target health professionals who provide obstetrical care, select women for caesarean section and/or perform caesareans. This training aims to improve the performance of health care personnel in managing four main clinical situations: women with previous caesarean section, pre-eclampsia, prolonged labor and fetal distress. With the support of an external facilitator (principal investigator), the audit process will be launched in each center in accordance with the approach proposed by WHO. Information on caesarean sections collected during the pre-intervention period will be analyzed according to the algorithms. A synthesis of the results will be addressed to the hospital director and the head of the maternity unit who will plan an audit meeting with the staff. Recommendations for action will be drawn and the implementation of each action will be monitored by the research team. Individual feedback of audit findings, recommendations to health care personnel and continuous training with vignettes will be implemented during one year using mobile phone (SMS).
2. Control group: No external intervention is planned for this group.

Randomization
The trial consists of a 6-month pre-intervention, a 1-year intervention period and a 6-month post-intervention period. After the 6-month pre-intervention data collection period (baseline), each hospital will be randomly assigned to either an intervention group or a control group. All participating hospitals will be simultaneously randomised, which minimize risks of allocation bias. To avoid level of care imbalance within each stratum, a computer blocked randomisation will be used to generate the allocation sequence. Each block will included two or four hospitals of similar level of care. Investigators will be informed of the allocation status of their hospital only after the baseline period and immediately before the implementation of the intervention in the intervention group.

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

The effect of the intervention will be measured by the change in the rate of non-medically justified caesarean sections among all caesarean sections between the periods before and after the intervention. Data on caesarean sections will be collected for 6 months before the intervention period and 6 months after the intervention period. They relate to clinical information for judging the appropriateness of indications for caesarean section according to objective criteria approved by a committee of independent experts.

Secondary outcome measures

1. Knowledge score of health care professionals using specific vignettes
2. Quality scores for the practice of caesareans based on objective criteria (specific tasks)
3. Score of resource availability using the complexity index proposed by WHO
4. Fatality rate of caesarean sections (mother and child)
Each of these outcomes will be measured before and after the intervention period.

Overall trial start date

01/03/2014

Overall trial end date

30/05/2016

Reason abandoned

Eligibility

Participant inclusion criteria

For the hospitals:
1. A minimum of 1000 deliveries per year
2. A minimum of 200 caesarean sections per year
3. The permanent availability of emergency caesarean section
4. The absence of current or recent experience in clinical audits for caesarean
5. Willingness to participate in the study is materialized by a written and signed ward agreement by the hospital director and the head of the maternity unit
6. District or regional hospital

For the patients:
We will include all women who deliver by caesarean section in selected hospitals during the study period: the first 100 caesarean sections for each center during the pre-intervention period (6 months) and the first 100 caesarean sections for each center in the post-intervention period.
.
For the health professionals:
All health professionals involved in the decision making process for a caesarean section: obstetricians, general practitioners, nurses and midwives.

Participant type

Patient

Age group

Adult

Gender

Female

Target number of participants

The target number for this trial is 4400 women (2200 in each group)

Participant exclusion criteria

For the hospitals:
1. University hospitals
2. Private hospitals

For the patients:
Women admitted in a center participating in the study but whose caesarean section was performed in another center

Recruitment start date

01/03/2014

Recruitment end date

30/05/2016

Locations

Countries of recruitment

Burkina Faso

Trial participating centre

Institut de Recherche pour le Développement (IRD)
Paris
75006
France

Sponsor information

Organisation

Research Institute for Development (Institut de Recherche pour le Développement [IRD]) (France)

Sponsor details

Faculte de Pharmacie de Paris
4 Avenue de l'Observatoire
Paris
75006
France
-
alexandre.dumont@ird.fr

Sponsor type

Research organisation

Website

http://en.ird.fr/

Funders

Funder type

Charity

Funder name

Canadian Institutes of Health Research

Alternative name(s)

Instituts de Recherche en Santé du Canada, CIHR

Funding Body Type

government organisation

Funding Body Subtype

Federal/National Government

Location

Canada

Funder name

UNICEF – WHO/OMS – UNFPA – ONU Femmes/UN Women

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

French Embassy in Burkina Faso

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2016 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/27769190

Publication citations

Additional files

Editorial Notes

24/10/2016: Publication reference added.